Loading...
XJPX2931
Market cap346mUSD
Jan 15, Last price  
397.00JPY
1D
-0.25%
1Q
-7.67%
Jan 2017
-69.18%
IPO
140.31%
Name

Euglena Co Ltd

Chart & Performance

D1W1MN
XJPX:2931 chart
P/E
—
P/S
1.22
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
6.00%
Rev. gr., 5y
26.17%
Revenues
44.39b
+90.59%
1,166,024,0001,585,688,0002,091,978,0003,046,348,0005,924,356,00011,103,230,00013,886,603,00015,174,582,00013,967,671,00013,317,316,00023,291,848,00044,392,000,000
Net income
-2.68b
L-17.01%
204,871,000197,438,000482,540,000118,177,000469,639,000673,344,000785,886,000-1,252,194,000-9,798,460,000-1,486,498,000-3,227,952,000-2,679,000,000
CFO
924m
-38.45%
250,538,00086,174,000163,544,000-7,805,000620,966,000913,588,000153,756,000-1,238,020,0001,089,392,000-1,217,472,0001,501,276,000924,000,000
Earnings
Feb 12, 2025

Profile

Euglena Co., Ltd. engages in the research, development, production, and sale of microalgae. It operates through Healthcare Business and Energy/Environment Business segments. The company also manufactures and sells foods and cosmetics using euglena. In addition, it offers health foods, beverages, confectionery, and sports food products. Further, the company develops biofuel technology and environmental related technology for microalgae; and invests in biotechnology related business. It distributes its products at convenience stores, drugstores, supermarkets, beauty salons, and variety shops. The company was incorporated in 2005 and is headquartered in Tokyo, Japan.
URL
https://www.euglena.jp/
IPO date
Dec 20, 2012
Employees
865
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2022‑122021‑092020‑092019‑092018‑092017‑092016‑092015‑09
Income
Revenues
44,392,000
90.59%
Cost of revenue
13,396,000
Unusual Expense (Income)
NOPBT
30,996,000
NOPBT Margin
69.82%
Operating Taxes
272,000
Tax Rate
0.88%
NOPAT
30,724,000
Net income
(2,679,000)
-17.01%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
2,717,000
Long-term debt
19,519,000
Deferred revenue
Other long-term liabilities
814,000
Net debt
12,282,000
Cash flow
Cash from operating activities
924,000
CAPEX
(496,000)
Cash from investing activities
1,233,000
Cash from financing activities
(2,993,000)
FCF
35,454,906
Balance
Cash
9,954,000
Long term investments
Excess cash
7,734,400
Stockholders' equity
5,678,000
Invested Capital
35,715,000
ROIC
83.36%
ROCE
66.34%
EV
Common stock shares outstanding
112,128
Price
980.00
12.13%
Market cap
109,885,019
24.74%
EV
122,169,019
EBITDA
34,171,000
EV/EBITDA
3.58
Interest
544,000
Interest/NOPBT
1.76%